Impact News +++ Quantum eMotion Corp.: Quantum eMotion′s Partner, Energy Plug Technologies Corp., Secures Pre-Order for... (Newsfile) +++ QUANTUM EMOTION Aktie +3,57%

Gewinn & Umsatz News zur INCYTE Aktie

>INCYTE Aktienkurs

79.05 EUR (Tradegate)

Ask: 79.44 EUR / 127 Stück

Bid: 78.66 EUR / 128 Stück

Tagesumsatz: 0 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

INCYTE Aktie über LYNX handeln

Intraday

1 Jahr

>INCYTE Performance

1 Woche: +4,3%

1 Monat: +12,3%

3 Monate: +30,8%

6 Monate: +52,9%

1 Jahr: +31,6%

laufendes Jahr: +20,1%

>INCYTE Aktie

Name:

INCYTE DL-,001

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US45337C1027 / 896133

Symbol/ Ticker:

ICY (Frankfurt) / INCY (NASDAQ)

Kürzel:

FRA:ICY, ETR:ICY, ICY:GR, NASDAQ:INCY

Index:

S&P500

Webseite:

https://incyte.com/

Profil:

Incyte Corporation is a biopharmaceutical company ..
>Volltext..

Marktkapitalisierung:

15601.58 Mio. EUR

Unternehmenswert:

13582.71 Mio. EUR

Umsatz:

3935.52 Mio. EUR

EBITDA:

931.36 Mio. EUR

Nettogewinn:

747.51 Mio. EUR

Gewinn je Aktie:

3.86 EUR

Schulden:

36.4 Mio. EUR

Liquide Mittel:

1678.04 Mio. EUR

Operativer Cashflow:

860.83 Mio. EUR

Bargeldquote:

1.89

Umsatzwachstum:

8.09%

Gewinnwachstum:

713.88%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

1 Insider verkaufte innerhalb der letzten 30 Tage Aktien im Wert von 375.559 USD.

Suchwörter:

INCYTE

Letzte Datenerhebung:

29.10.25

>INCYTE Kennzahlen

Aktien/ Unternehmen:

Aktien: 195.28 Mio. St.

Frei handelbar: 98.79%

Leerverk. Aktien: 4.8%

Rückkaufquote: -0.18%

Mitarbeiter: 2617

Umsatz/Mitarb.: 1.39 Mio. EUR

Analysten:

Analystenrating: Neutral

Kursziel: -7.1%

Bewertung:

KGV: 21.68

KGV lG: 15.09

KUV: 3.99

KBV: 4.44

PEG-Ratio: 0.02

EV/EBITDA: 14.58

Rentabilität:

Bruttomarge: 91.43%

Gewinnmarge: 18.99%

Operative Marge: 21.69%

Managementeffizenz:

Gesamtkaprendite: 16.61%

Eigenkaprendite: 24.3%

>INCYTE Peer Group

Es sind 596 Aktien bekannt.

>INCYTE Chart & Kurs - NASDAQ

>INCYTE Gewinn & Umsatz News

28.10.25 - 13:18	Incyte Corporation Q3 Profit Increases, Beats Estimates (AFX)
	WASHINGTON (dpa-AFX) - Incyte Corporation (INCY) revealed a profit for its third quarter that Increased from the same period last year and beat the Street estimates.The company's earnings totaled ......

21.10.25 - 15:06	Incytes Quarterly Earnings Preview: What You Need to Know (Barchart)
	Incyte will release its third-quarter earnings later this month, and analysts anticipate a double-digit bottom-line growth....

17.09.25 - 08:48	Incyte Reports Encouraging 24-Week Results From Phase 3 STOP-HS Program Of Povorcitinib (AFX)
	WASHINGTON (dpa-AFX) - Incyte Corporation (INCY) on Wednesday announced encouraging 24-week data from the pivotal Phase 3 STOP-HS program evaluating povorcitinib in adults with hidradenitis suppur......

29.07.25 - 15:01	Incyte Q2 Results Top Estimates (AFX)
	WASHINGTON (dpa-AFX) - Incyte Corp. (INCY) on Tuesday reported net income of $405.0 million or $2.04 per share for the second quarter, compared to a net loss of $444.60 million or $2.04 per share ......

10.07.25 - 15:06	Incyte′s Q2 2025 Earnings: What to Expect (Barchart)
	Incyte is gearing up to report its fiscal second-quarter earnings later this month, with analysts forecasting a sharp surge in profitability, projecting triple-digit year-over-year profit growth....

29.04.25 - 14:18	Incyte Q1 Results Top Estimates (AFX)
	WASHINGTON (dpa-AFX) - Incyte Corp. (INCY) on Tuesday reported net income of $158.20 million or $0.80 per share for the first quarter, lower than $169.55 million or $0.75 per share in the prior-ye......

16.04.25 - 13:30	Incyte Earnings Preview: What to Expect (Barchart)
	Incyte is all set to release its fiscal first-quarter earnings later this month, and analysts project a high double-digit profit growth....

09.03.25 - 04:01	Lilly Reveals Positive Phase 3 Results For Adolescent Alopecia Areata Treatment With Baricitinib (AFX)
	INDIANAPOLIS (dpa-AFX) - Eli Lilly and Co. (LLY) and Incyte's (INCY) late-breaking results from Phase 3 BRAVE-AA-PEDS study found adolescent patients (ages 12 to under 18) with severe alopecia are......

10.02.25 - 14:18	Incyte Q4 Adj. EPS Misses Estimates, Revenues Beat; Sees Revenue Growth In FY25 (AFX)
	WASHINGTON (dpa-AFX) - Pharma company Incyte Corp. (INCY) reported Monday slightly higher earnings in its fourth quarter with strong growth in revenues. Adjusted earnings missed the Wall Street vi......

17.01.25 - 09:30	What You Need to Know Ahead of Incytes Earnings Release (Barchart)
	Biopharma major Incyte is expected to announce its fourth-quarter results later this month and analysts expect a significant double-digit growth in earnings....

07.12.24 - 13:43	Incyte Announces Positive Results From Phase 3 Trial Evaluating Retifanlimab (Zynyz®) (Reuters EN)
	BRIEF-Incyte Announces Positive Results From Phase 3 Trial Evaluating Retifanlimab (Zynyz®) Dec 7 (Reuters) - INCYTE ANNOUNCES POSITIVE RESULTS FROM PHASE 3 TRIAL EVALUATING RETIFANLIMAB (ZYNYZ®) IN COMBINATION WITH PLATINUM-BASED CHEMOTHERAPY IN PATIENTS WITH NON-SMALL CELL LUNG CANCER INCYTE CORP - ANNOUNCES POSITIVE RESULTS FROM PHASE 3 TRIAL...

29.10.24 - 16:05	Incyte climbs on 2024 sales forecast lift for top-selling drug Jakafi (Reuters EN)
	Incyte climbs on 2024 sales forecast lift for top-selling drug Jakafi...

29.10.24 - 14:58	Incyte raises 2024 sales forecast for top-selling drug Jakafi (Reuters EN)
	Incyte raises 2024 sales forecast for top-selling drug Jakafi...

29.10.24 - 13:01	Incyte Corporation Q3 Profit Drops, Inline With Estimates (AFX)
	WASHINGTON (dpa-AFX) - Incyte Corporation (INCY) released earnings for third quarter that decreased from last year in line with the Street estimates.The company's bottom line came in at $106.456 m......

29.10.24 - 12:26	Incyte Reports 2024 Third Quarter Financial Results And Provides Updates On Key Clinical Programs (Reuters EN)
	Incyte Reports 2024 Third Quarter Financial Results And Provides Updates On Key Clinical Programs...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Vor einem Fremden tue nichts Heimliches, denn du weißt nicht, was er davon an den Tag bringt. - Altes Testament: Buch Jesus Sirach

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram